Featured Research

from universities, journals, and other organizations

Scientists Raise Caution About Effects Of HRT On Hearing

Date:
February 25, 2004
Source:
University Of Rochester Medical Center
Summary:
A small pilot study funded by the National Institutes of Health suggests that women who undergo hormone-replacement therapy (HRT) may run the risk of diminished hearing.

A small pilot study funded by the National Institutes of Health suggests that women who undergo hormone-replacement therapy (HRT) may run the risk of diminished hearing. Depending on the measure, HRT recipients on average did anywhere from 10 to 30 percent worse on hearing tests than women who had not received HRT, says Robert D. Frisina, Ph.D., professor of Otolaryngology at the University of Rochester Medical Center.

Related Articles


Frisina and colleagues from the International Center for Hearing and Speech Research (ICHSR), an NIH-funded group of scientists from the University of Rochester and the National Technical Institute for the Deaf at Rochester Institute of Technology, presented the work this week at the annual meeting of the Association for Research in Otolaryngology in Daytona, Fla.

The scientists used three tests to compare the hearing of 32 women between the ages of 60 and 86 who had had hormone therapy to 32 other women who had not. While the HRT group performed more poorly across the board, it was in complex settings – such as the ability to decipher a sentence while listening to someone amid a loud backdrop, like the cacophony at a cocktail party – that the HRT group fared worst.

"It's important to alert women that there could be another significant side effect of hormone-replacement therapy," says Frisina. "We know these findings clearly apply to the 64 women we studied. What we can't say, from such a small number of people, is the extent to which they apply to everyone. A much larger study needs to be done.

"These results are very surprising. We thought hormones would help women hear better, because of the presence of estrogen receptors in the ear. This is the opposite of what we were expecting."

The HRT group performed most poorly on a test aimed at measuring not just how well the ear actually detects a sound, but also how well the brain processes that information. A large portion of age-related hearing loss, called presbycusis, involves the brain's faltering ability to process information. It's not much different from the work your computer does when billions of electronic signals registering as "0s" and "1s" flow in from the Internet – the computer takes those signals and makes words and graphics which we grasp quickly.

Our brains do similar work, filtering out unneeded information and prioritizing and organizing other information in a way we can understand. It's this sophisticated system that decreases as we get older, the team has found – and it's this ability that is most diminished in women who have received HRT compared to women who have not. Women in the HRT group on average performed this task 30 percent less effectively than other women.

"This would be most noticeable in situations where there is a lot going on, where there's a lot of background noise," says Frisina. "The most obvious situation is a party where a lot of people are talking, and you're trying to listen to one particular person. It's as if the aging process, when it comes to their ability to hear, was accelerated in these women.

"Our findings raise concerns. Women should talk to their doctors before making any decisions. And certainly, the findings call for more extensive studies."

Frisina is part of the world's foremost group on age-related hearing loss, a group currently funded with a five-year, $6.3-million grant from the National Institutes of Health. The group has been continually funded through five-year grants from NIH since 1993 and draws upon extensive research on human hearing, at RIT, with expertise in neuroscience from the University of Rochester.

Other scientists have previously linked HRT to increased risk of breast cancer, heart attacks, stroke, and dementia. The Rochester team presented the new results in a poster in Daytona and will submit their findings to a journal for publication.

The work was presented in Daytona by researcher Patricia Guimaraes of the University's Department of Otolaryngology. Also contributing to the work besides Frisina were researchers Susan Frisina of the University of Rochester; audiologist Frances Mapes of Rochester Institute of Technology; SungHee Kim of Daegu, South Korea, who is visiting Frisina's lab at the University; and D. Robert Frisina of RIT. All are part of the NIH-funded hearing and speech center.


Story Source:

The above story is based on materials provided by University Of Rochester Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Rochester Medical Center. "Scientists Raise Caution About Effects Of HRT On Hearing." ScienceDaily. ScienceDaily, 25 February 2004. <www.sciencedaily.com/releases/2004/02/040225071355.htm>.
University Of Rochester Medical Center. (2004, February 25). Scientists Raise Caution About Effects Of HRT On Hearing. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2004/02/040225071355.htm
University Of Rochester Medical Center. "Scientists Raise Caution About Effects Of HRT On Hearing." ScienceDaily. www.sciencedaily.com/releases/2004/02/040225071355.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins